CADI™ models and proto-models already built
Bio-Modeling Systems R& D team has already made twelve CADI™ models & « proto-models », in 5 major medical areas for optimization of the drug development process and the diversification of drugs applications. CADI™ models for Industrial biotech and the generation of “improved” proteins were recently developed
- Systemics: Breast cancer ³, Tamoxifen resistance ³, Metastasis²

- Infection / Immunology:
Antibacterial bio-agent 4,Hepatitis C¹ , CFS¹
- Tissue differentiation: Adipocytes growth control¹, Müllerian regression²
- Metabolism: Hypercholesterolemia¹,
- Industrial biotech:
Program Synthons: Collaborative research platform
- Targeted Variant Proteins:
CADI™-TAPE Process³ (antibodies, enzymes,long peptides etc..)
- CNS: Creutzfeldt-Jakob², Alzheimer disease¹
1 : Models ready for experimental evaluation 2 : Experimentally validated models 3: Experimentally validated and published models 4 Experimentally validated and industrially exploited
BMSystems: a leading Systems Biology / Integrative Biology company that delivers
Copyright © 2010 Bio-Modeling Systems / bioModeling Systems / BMSystems. All rights reserved bmsystems(at)bmsystems.net or biomodeling(at)bmsystems.net